- Home
- RDVT vs DNA Comparison
RDVT vs DNA Comparison
Compare RDVT & DNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RDVT
- DNA
- Stock Information
- Founded
- RDVT 2017
- DNA 2008
- Country
- RDVT United States
- DNA United States
- Employees
- RDVT N/A
- DNA N/A
- Industry
- RDVT Computer Software: Prepackaged Software
- DNA Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- RDVT Technology
- DNA Health Care
- Exchange
- RDVT Nasdaq
- DNA Nasdaq
- Market Cap
- RDVT 550.8M
- DNA 562.1M
- IPO Year
- RDVT N/A
- DNA N/A
- Fundamental
- Price
- RDVT $38.84
- DNA $10.82
- Analyst Decision
- RDVT Strong Buy
- DNA Hold
- Analyst Count
- RDVT 1
- DNA 6
- Target Price
- RDVT $25.00
- DNA $37.80
- AVG Volume (30 Days)
- RDVT 104.8K
- DNA 1.8M
- Earning Date
- RDVT 02-27-2025
- DNA 02-25-2025
- Dividend Yield
- RDVT 0.77%
- DNA N/A
- EPS Growth
- RDVT N/A
- DNA N/A
- EPS
- RDVT 0.36
- DNA N/A
- Revenue
- RDVT $70,685,000.00
- DNA $217,951,000.00
- Revenue This Year
- RDVT $24.88
- DNA N/A
- Revenue Next Year
- RDVT $14.52
- DNA N/A
- P/E Ratio
- RDVT $109.49
- DNA N/A
- Revenue Growth
- RDVT 21.43
- DNA N/A
- 52 Week Low
- RDVT $16.56
- DNA $5.26
- 52 Week High
- RDVT $43.44
- DNA $64.40
- Technical
- Relative Strength Index (RSI)
- RDVT 50.72
- DNA 43.22
- Support Level
- RDVT $38.57
- DNA $11.21
- Resistance Level
- RDVT $41.80
- DNA $15.96
- Average True Range (ATR)
- RDVT 1.90
- DNA 1.85
- MACD
- RDVT -0.04
- DNA -0.40
- Stochastic Oscillator
- RDVT 41.92
- DNA 0.08
About RDVT Red Violet Inc.
Red Violet Inc is a software and services company. It specializes in big data analysis, providing cloud-based, mission-critical information solutions to enterprises in a variety of industries. Through its CORE data fusion platform, it provides mission-critical information about individuals, businesses, and assets.
About DNA Ginkgo Bioworks Holdings Inc.
Ginkgo Bioworks Holdings Inc is the platform for cell programming, providing flexible, end-to-end services that solve challenges for organizations across diverse markets, from food and agriculture to pharmaceuticals to industrial and specialty chemicals. The Company reorganized its operations into two operating and reportable segments: Cell Engineering and BiosecurityThe majority of revenue in the company comes from the Biosecurity segment, which charges fees for data analytics and services.